Department of Kinesiology, Faculty of Health Sciences, Western University, London, Ontario, Canada.
Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
PLoS One. 2024 Jul 30;19(7):e0306439. doi: 10.1371/journal.pone.0306439. eCollection 2024.
Treatment and management of Type 2 Diabetes (T2D) includes physical activity, nutrition, and pharmacological management. Recently, the importance of reducing and breaking up sedentary behaviour has become recognized. This review aimed to summarize and synthesize the effectiveness of interventions in reducing and/or breaking up sedentary behaviour and cardiometabolic biomarkers in adults with T2D. A study protocol was preregistered on PROSPERO (CRD42022357281) and a database search (PubMed, EMBASE, Scopus, Web of Science, PsycINFO, SPORTDiscus, CINAHL, and Cochrane Library) was conducted on 16/09/2022 and updated on 03/01/2024. This review followed PRISMA guidelines and study quality was assessed with the Cochrane risk of Bias Tools. Twenty-eight articles were included in the review. The meta-analysis of short-term (Range: 3 hours- 4 days) sedentary behaviour interventions found significant improvement in continuous interstitial glucose measured for 24 hours after the sedentary behaviour intervention compared to control (SMD:-0.819,95%CI:-1.255,-0.383,p<0.001). Similarly, there was a significant improvement in postprandial interstitial glucose after the sedentary behaviour intervention compared to control (SMD:-0.347,95%CI:-0.584,-0.110,p = 0.004). Ten out of eleven longer-term (Range: 5 weeks- 3 years) sedentary behaviour interventions improved at least one measure of sedentary behaviour compared to control. Eight out of eight longer-term sedentary behaviour interventions improved at least one cardiometabolic biomarker compared to control. Reducing sedentary behaviour, independent of physical activity, can improve glycemic control in adults with T2D. Further, sedentary behaviour may be a feasible/ sustainable behaviour change.
2 型糖尿病(T2D)的治疗和管理包括身体活动、营养和药物管理。最近,减少和打破久坐行为的重要性已经得到认可。本综述旨在总结和综合干预措施在减少和/或打破久坐行为和 T2D 成年人的心血管代谢生物标志物方面的有效性。研究方案已在 PROSPERO(CRD42022357281)上预先注册,并于 2022 年 9 月 16 日和 2024 年 1 月 3 日在 PubMed、EMBASE、Scopus、Web of Science、PsycINFO、SPORTDiscus、CINAHL 和 Cochrane Library 进行了数据库搜索。本综述遵循 PRISMA 指南,并使用 Cochrane 偏倚风险工具评估研究质量。本综述共纳入 28 篇文章。短期(范围:3 小时-4 天)久坐行为干预的荟萃分析发现,与对照组相比,久坐行为干预后 24 小时内连续间质葡萄糖测量有显著改善(SMD:-0.819,95%CI:-1.255,-0.383,p<0.001)。同样,与对照组相比,餐后间质葡萄糖也有显著改善(SMD:-0.347,95%CI:-0.584,-0.110,p=0.004)。11 项长期(范围:5 周-3 年)久坐行为干预中有 10 项与对照组相比至少有一项久坐行为指标得到改善。8 项长期久坐行为干预中有 8 项与对照组相比至少有一项心血管代谢生物标志物得到改善。减少久坐行为,独立于体力活动,可改善 T2D 成年人的血糖控制。此外,久坐行为可能是一种可行/可持续的行为改变。